Treatment for juvenile diabetes
Patent Number: 6288301
Date of First Priority Issue: Monday December 14th, 1992
Date Issued: Tuesday September 11th, 2001
Assignee: Waratah Pharmaceuticals, Inc. (CA); The General Hospital Corporation (Boston, MA
Inventors: Nardi, Ronald V. (Sudbury, MA); Brand, Stephen J. (Lincoln, MA) )
From Class: Use
Comments: No comments
This patent teaches how to treat diabetes by the activation of endogenous stem cells through administration of gastrin and EGF. This patent is in clinical trials.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.